- Business Development Officer
Noah Schwartz, MBA
Noah is responsible for technology development and commercialization at Techna. He endeavors to sustainably maximize the impact of innovation through the marketing of new products and services that benefit the healthcare ecosystem.
Prior to joining Techna, Noah has successfully developed and marketed novel health technologies for Diagand Antibodies, Aerotel Medical Systems, TCE Group and Policy Medical. Noah studied biology and mechanical engineering at the University of Toronto and holds an MBA from the Schulich School of Business with a specialization in Health Industry Management.